Booster shots could cut Europe's COVID hospitalisations by up to 800,000 -EU
Reuters
Published Jan 27, 2022 12:14
BRUSSELS (Reuters) - Booster shots could reduce future hospitalisations in Europe by at least half a million, the European Union's public health agency said on Thursday, even as the Omicron variant spreads at an unprecedented pace.
"The current uptake of a booster dose achieved by early January may reduce future Omicron hospital admissions by 500,000 - 800,000" in Europe, the European Centre for Disease prevention and Control (ECDC) said.
The figures cover the 27-nation EU plus Norway, Iceland and Liechtenstein.
Currently about 70% of the EU's population of 450 million has been fully vaccinated and half of them have received a booster.
"Extending the booster programme to all previously vaccinated individuals could reduce admissions by another 300,000 - 500,000," the ECDC said.
Although Omicron cases in Europe are increasing at an unprecedented speed, with infection rates three times as high as the highest peak so far, many countries may already be at a turning point, the EU said.
"Whilst in some Member States, the peak of infection appears to have been reached recently, the pandemic is not over," EU health commissioner Stella Kyriakides added.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.